Ads
-
Related paper
- EVALUATION OF MACULAR THICKNESS IN TYPE -2 DIABETICS ON PIOGLITAZONE
- EVALUATION OF CENTRAL CORNEAL THICKNESS AMONG TYPE 2 DIABETICS AND AGE MATCHED CONTROLS A COMPARATIVE STUDY
- A COMPARATIVE STUDY OF SERUM ASCORBATE BETWEEN NEWLY DIAGNOSED TYPE 2 DIABETICS AND LONG STANDING TYPE 2 DIABETICS ON TREATMENT
- Contrast Sensitivity and Macular Thickness in Patients with Diabetic Macular Odema Following Grid Laser Photocoagulation
- Analyse the Efficacy and Safety of Intravitreal Injection of Biosimilar Ranibizumab on Central Macular Thickness and Visual Outcome in Patients of Macular Edema
- Relationship of Serum HbA1c and Fasting Serum Lipids with Central Macular Thickness in Patients with Type 2 Diabetes Mellitus
- COMPARISON OF PEAK EXPIRATORY FLOW RATE IN TYPE II DIABETICS WITH NON -DIABETICS
- Audio and Visual Response Time of Type 2 Diabetics and Non-Diabetics
- Cross sectional case control study to establish the thickness of ganglion cell-inner plexiform (GC-IPL) layer thickness in type 2 diabetis (Type 2 DM) patients with diabetic retinopathy (DR) and compa
- The impact of three combinations vildagliptin/metformin, vildagliptin/pioglitazone, and metformin/pioglitazone on glycemic control and atherogenic dyslipidemia in patients with Type 2 diabetes mellitus